Pharmaceutical

Medicxi and Starpharma to develop dendrimer-based cancer treatments

Medicxi has partnered with Starpharma for the formation of Petalion Therapeutics to develop dendrimer-based oncology treatments.

Apr 9, 2024 - 00:00
Medicxi and Starpharma to develop dendrimer-based cancer treatments
Medicxi has partnered with Starpharma for the formation of Petalion Therapeutics to develop dendrimer-based oncology treatments.
Read the original article

Tags:

Previous Article

AdAlta and SYNthesis to form AdCella for advanced cancer treatments

Next Article

BMS and 2seventy bio’s Abecma gains approval for multiple myeloma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: China’s complicated role in malaria control in Africa

Opinion: China’s complicated role in malaria control in...

May 15, 2023

Embryo loss is integral to IVF. Alabama’s ruling equating embryos with children jeopardizes its practice

Embryo loss is integral to IVF. Alabama’s ruling equati...

Feb 23, 2024

CMS sets up negotiating framework for expensive sickle cell disease gene therapies

CMS sets up negotiating framework for expensive sickle ...

Jan 31, 2024